Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 25% ± 12% | |
glutamatergic neuron | 4 studies | 28% ± 12% | |
dendritic cell | 3 studies | 23% ± 7% | |
macrophage | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 22% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3089.78 | 1445 / 1445 | 100% | 67.39 | 183 / 183 |
stomach | 100% | 1990.16 | 359 / 359 | 100% | 63.28 | 286 / 286 |
ovary | 100% | 2752.44 | 180 / 180 | 100% | 71.87 | 429 / 430 |
intestine | 100% | 3080.39 | 966 / 966 | 100% | 61.02 | 525 / 527 |
skin | 100% | 3376.31 | 1808 / 1809 | 99% | 53.54 | 469 / 472 |
breast | 100% | 2346.55 | 459 / 459 | 99% | 38.01 | 1104 / 1118 |
lung | 100% | 2177.18 | 576 / 578 | 98% | 41.13 | 1137 / 1155 |
bladder | 100% | 3108.00 | 21 / 21 | 98% | 43.25 | 494 / 504 |
pancreas | 100% | 1511.01 | 327 / 328 | 98% | 29.09 | 174 / 178 |
uterus | 100% | 3657.38 | 170 / 170 | 97% | 44.89 | 446 / 459 |
prostate | 100% | 2575.87 | 245 / 245 | 96% | 29.42 | 484 / 502 |
brain | 96% | 2239.32 | 2544 / 2642 | 99% | 29.74 | 698 / 705 |
kidney | 100% | 1880.88 | 89 / 89 | 94% | 21.17 | 847 / 901 |
thymus | 100% | 1844.61 | 652 / 653 | 94% | 19.37 | 567 / 605 |
adrenal gland | 100% | 1916.98 | 258 / 258 | 87% | 18.62 | 200 / 230 |
liver | 99% | 1202.76 | 223 / 226 | 85% | 18.04 | 346 / 406 |
adipose | 100% | 2492.61 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 54.09 | 80 / 80 |
muscle | 100% | 6811.05 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2202.17 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.65 | 1 / 1 |
blood vessel | 100% | 2548.01 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 2842.47 | 915 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 42.45 | 44 / 45 |
heart | 96% | 1923.95 | 828 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 39.38 | 27 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032259 | Biological process | methylation |
GO_0033146 | Biological process | regulation of intracellular estrogen receptor signaling pathway |
GO_0006338 | Biological process | chromatin remodeling |
GO_1904037 | Biological process | positive regulation of epithelial cell apoptotic process |
GO_0071932 | Biological process | replication fork reversal |
GO_0051591 | Biological process | response to cAMP |
GO_0019919 | Biological process | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine |
GO_0045943 | Biological process | positive regulation of transcription by RNA polymerase I |
GO_0045600 | Biological process | positive regulation of fat cell differentiation |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_2000171 | Biological process | negative regulation of dendrite development |
GO_0043596 | Cellular component | nuclear replication fork |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0070611 | Molecular function | histone H3R2 methyltransferase activity |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0070577 | Molecular function | lysine-acetylated histone binding |
GO_0035642 | Molecular function | histone H3R17 methyltransferase activity |
GO_0008013 | Molecular function | beta-catenin binding |
GO_0042054 | Molecular function | histone methyltransferase activity |
GO_0008469 | Molecular function | histone arginine N-methyltransferase activity |
GO_0008276 | Molecular function | protein methyltransferase activity |
GO_0016274 | Molecular function | protein-arginine N-methyltransferase activity |
GO_0035242 | Molecular function | protein-arginine omega-N asymmetric methyltransferase activity |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0030374 | Molecular function | nuclear receptor coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CARM1 |
Protein name | Coactivator associated arginine methyltransferase 1 type I protein arginine methyltransferase (EC 2.1.1.319) Histone-arginine methyltransferase CARM1 (EC 2.1.1.319) (Coactivator-associated arginine methyltransferase 1) (Protein arginine N-methyltransferase 4) |
Synonyms | PRMT4 |
Description | FUNCTION: Methylates (mono- and asymmetric dimethylation) the guanidino nitrogens of arginyl residues in several proteins involved in DNA packaging, transcription regulation, pre-mRNA splicing, and mRNA stability . Recruited to promoters upon gene activation together with histone acetyltransferases from EP300/P300 and p160 families, methylates histone H3 at 'Arg-17' (H3R17me), forming mainly asymmetric dimethylarginine (H3R17me2a), leading to activates transcription via chromatin remodeling . During nuclear hormone receptor activation and TCF7L2/TCF4 activation, acts synergically with EP300/P300 and either one of the p160 histone acetyltransferases NCOA1/SRC1, NCOA2/GRIP1 and NCOA3/ACTR or CTNNB1/beta-catenin to activate transcription (By similarity). During myogenic transcriptional activation, acts together with NCOA3/ACTR as a coactivator for MEF2C (By similarity). During monocyte inflammatory stimulation, acts together with EP300/P300 as a coactivator for NF-kappa-B (By similarity). Acts as a coactivator for PPARG, promotes adipocyte differentiation and the accumulation of brown fat tissue (By similarity). Plays a role in the regulation of pre-mRNA alternative splicing by methylation of splicing factors (By similarity). Also seems to be involved in p53/TP53 transcriptional activation (By similarity). Methylates EP300/P300, both at 'Arg-2142', which may loosen its interaction with NCOA2/GRIP1, and at 'Arg-580' and 'Arg-604' in the KIX domain, which impairs its interaction with CREB and inhibits CREB-dependent transcriptional activation . Also methylates arginine residues in RNA-binding proteins PABPC1, ELAVL1 and ELAV4, which may affect their mRNA-stabilizing properties and the half-life of their target mRNAs (By similarity). Acts as a transcriptional coactivator of ACACA/acetyl-CoA carboxylase by enriching H3R17 methylation at its promoter, thereby positively regulating fatty acid synthesis (By similarity). Independently of its methyltransferase activity, involved in replication fork progression: promotes PARP1 recruitment to replication forks, leading to poly-ADP-ribosylation of chromatin at replication forks and reduced fork speed . . |
Accessions | ENST00000586298.1 K7EK20 ENST00000588947.5 Q86X55 K7EIQ8 K7EQA8 ENST00000710361.1 ENST00000344150.8 [Q86X55-1] ENST00000327064.9 [Q86X55-3] ENST00000590039.5 ENST00000590699.5 K7ERM3 ENST00000589693.1 ENST00000586221.5 K7EQB9 A0AA34QVH5 K7EPK1 |